Edanz

Edanz is a scientific research support service dedicated to providing innovative solutions to the challenges faced by the international research community from individual researchers and clinicians to large institutions. Since its inception in 1995 as an English editing company, Edanz has continually evolved to cater to the diverse needs of researchers. The company offers a range of services including high-quality language and academic editing, publication support, and tools such as Journal Selector and MY Manuscript to simplify the publication process. Moreover, Edanz has expanded its offerings to include Edanz Pharma, which supports Medical Affairs teams in planning and executing evidence generation strategies. Its teams consist of researchers, journal editors, peer reviewers, and medical communications specialists. In 2019, Edanz became a part of the M3 Group listed on the Tokyo Stock Exchange First Section (Securities code 2413). Through its commitment to understanding and addressing the needs of researchers, Edanz has established itself as a valuable resource, providing guidance and support at every stage of the research process. With its growing suite of services and its integration into the M3 Group, Edanz is positioned to continue its impact on the international research community, offering innovative scientific solutions to support researchers in communicating their work globally.